Surgify Halo Drill Recall Issued Over Burr Breakage Risk
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
SURGIFY MEDICAL OY is recalling 53 units of the Surgify Halo 5.4 mm Extendable device due to potential burr breakage during surgery.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 5, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
SURGIFY MEDICAL OY initiated a voluntary recall of the Surgify Halo device because of the potential for burr breakage during bi-portal endoscopic spinal surgery (BESS).
Which Products Are Affected
The recall covers Surgify Halo, 5.4 mm, Extendable, Model/Catalog Number: 54.000.SEE.H1. A total of 53 units are affected. The UDI is 06429830116998, and the recall applies to all lots until the IFU update has been implemented. Distribution was limited to US Nationwide in the states of MN, MA, IN, LA, CA, NY, and FL.
What You Should Do
Consumers and healthcare facilities should follow instructions provided by the recalling firm regarding the affected devices.
Why This Matters
The Class II recall addresses a device defect that could lead to breakage during spinal procedures.
Source
FDA recall number Z-2564-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (847 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 5, 2026.
Frequently Asked Questions
Common questions about this FDA recall.